10/31/14 AMED 26.10 Amedisys Inc $AMED Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 1, 2014 at 10:37 PM

10/31/14 AMED 26.10 Amedisys Inc $AMED Hit a 52 week high of 26.34 Closing the day 10/31/14 at 26.10 +0.82 +3.24% With a day low of 25.33 and a total volume of 784,700.

AMED Recent Posts: http://investorshangout.com/Amedisys-Inc-AMED-53302/

AMED Amedisys Inc Recent Headline News

Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 10.50 (+0.02), EMR: 64.06 (+0.64), AMED: 26.10 (+0.82), AAPL: 108.00 (+1.02)

Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.84 (+0.02), ACMP: 62.29 (-0.64), AMAG: 33.01 (-0.95), AMED: 26.10 (+0.82), ACCO: 8.23 (+0.33)

Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 26.10 (+0.82)

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.99 (+1.39), ABMD: 32.79 (+1.44), BGFV: 12.31 (+0.29), RDCM: 8.60 (+0.10), AMED: 26.10 (+0.82), MRCY: 13.98 (-0.07), OMER: 16.57 (unch), ESBF: 18.66 (+0.07), EVOK: 6.70 (+0.76), IQNT: 16.83 (+1.10), KONA: 22.53 (+0.57), TQNT: 21.63 (+1.56), LAKE: 14.10 (-0.14), SAJA: 6.48 (-0.34)

Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 47.55 (-0.04), ZLTQ: 25.64 (-1.01), EA: 40.97 (+1.12), AMED: 26.10 (+0.82)

Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 25.81 (+0.14), SCTY: 59.18 (+2.85), JCP: 7.61 (-0.02), AMED: 26.10 (+0.82), RFMD: 13.01 (+0.94)

Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)

Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 26.10 (+0.82)

Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 26.10 (+0.82)

Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 26.10 (+0.82)

35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 26.10 (+0.82)

5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.46 (+0.26), RYAM: 28.53 (+0.67), CLF: 11.23 (+0.73), AMED: 26.10 (+0.82), LOCK: 16.91 (+0.01)

Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.46 (-0.02), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)

Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 26.10 (+0.82)

Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 26.10 (+0.82)

Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 26.10 (+0.82)

Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.75 (+0.51), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)

Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 43.15 (+0.18), AFAM: 29.44 (+0.69), AMED: 26.10 (+0.82), GTIV: 19.70 (+0.06)

Amedisys Inc (AMED) Stock Research Links

AMED Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Qapture Expands Global DeFi Reach with Key Acquisitions

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

TVEyes Archive+: Revolutionizing Media Intelligence

TVEyes Archive+ Takes Media Intelligence to New Heights Dishing out another update here, folks. TVEyes, the media intelligence powerhouse, just kicked off something that's got the potential to change the strategic media game—they call it Archive+. This tool isn’t just plundering old tapes; we're talking nearly two damn decades worth of historical broadcasts and...

Plan A Bets on AI in High-Stakes M&A Arena

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Vanda Pharmaceuticals Steps Into September Investor Talks

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Jamba's Cloud Whip: A Bold Blend in Beverage Scene

An Unexpected Shake-Up in the Beverage Game Folks, brace yourselves because Jamba's making some bold moves. I remember a time when a smoothie was just a smoothie, but now, they're stacking up a new deck with this fancy thing they're calling 'Cloud Whip'. It's basically a way to slap some extra protein onto your drink, with 10 grams coming at you like a freight train...

Equinix and CPP Investments Finalize $4B Data Center Deal

Equinix's Nordic Expansion: A Bold Move Ever seen a chess master make a move that completely shifts the board? That's what Equinix, Inc. and CPP Investments just pulled off with their acquisition of atNorth. With a hefty price tag of $4 billion, they're not just playing around. This deal puts Equinix at the center of the Nordic data hub, solidifying its foothold in a...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

ECARX Leverages AI for Next-Gen Auto Intelligence

ECARX's Latest Ventures in AI-Driven Mobility ECARX is making waves with its recent announcement to integrate Tencent Cloud's WorkBuddy AI with the Flyme AIOS operating system. It's not a small tweak; it's a big leap forward in pushing AI boundaries in automobiles. If you're looking at ECARX Holdings Inc. (Nasdaq: ECX) as an investment, here's the meat and potatoes of...

STANLEY Dives Into Flooring: Strategic Move or Risky Bet?

STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...

California's Insurance Shake-up: What It Means

There are plenty of rules in life that seem useless until suddenly they're not. California just passed a few fresh ones aiming to rein in the insurance sector. Zap your attention over to three new bills targeting fair insurance payouts and boosting coverage availability. It's a gust of wind in a typically frustrating insurance landscape, especially for the folks who've...